The present invention relates to in vitro cultured skin substitutes, and in particular to in vitro cultured skin substitutes that have improved barrier function. In some embodiments, improved barrier function is a result of improved culture conditions, while in other embodiments, improved barrier function results from genetic modification of keratinocytes. Improved culture conditions to improve barrier function include organotypic culture in the presence of linoleic acid and/or linoleic acid at about 75% humidity. Suitable genetic modifications for improving barrier function includes transfection with a DNA construct capable of expressing GKLF.

 
Web www.patentalert.com

< Recombinant thrombin receptor and related pharmaceuticals

< Multiplexed analysis of clinical specimens apparatus and method

> Antibody reactive with a protein having pre-B cell growth-supporting ability

> Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor

~ 00226